MedTrace Logo

Proton Beam Re-Irradiation in Thoracic Cancers

NCT02204761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-11-20

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies proton beam radiation therapy in treating patients with thoracic cancer that has come back and have received prior radiation therapy. Proton beam radiation therapy uses high energy protons to kill tumor cells and may cause less damage to normal tissue.

Conditions

  • Metastatic Malignant Neoplasm in the Lung
  • Recurrent Disease
  • Thoracic Neoplasm

Interventions

RADIATION

Proton Beam Radiation Therapy

Undergo proton beam re-irradiation therapy

Sponsors & Collaborators

Principal Investigators

  • Jing Zeng · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-09
Primary Completion
2017-09-07
Completion
2017-09-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204761 on ClinicalTrials.gov